Publications by authors named "Dominique Potin"

Claim this Profile
I
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORt.
Stephen B Gauld, Sebastien Jacquet, Donna Gauvin, Craig Wallace, Yibing Wang, Dominique Potin

J Pharmacol Exp Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists.
Jérôme Amaudrut, Maria A Argiriadi, Martine Barth, Eric C Breinlinger, Didier Bressac, Dominique Potin

Bioorg Med Chem Lett· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective and orally bioavailable protein kinase Cθ (PKCθ) inhibitors from a fragment hit.
Dawn M George, Eric C Breinlinger, Michael Friedman, Yang Zhang, Jianfei Wang, Dominique Potin

J Med Chem· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Dominique Potin

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors.
Jiaqiang Cai, D Jonathan Bennett, Zoran Rankovic, Maureen Dempster, Xavier Fradera, Dominique Potin

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).
Scott H Watterson, Zili Xiao, Dharmpal S Dodd, David R Tortolani, Wayne Vaccaro, Dominique Potin

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis.
Suzanne J Suchard, Dawn K Stetsko, Patricia M Davis, Stacey Skala, Dominique Potin

J Immunol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Dominique Potin

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
Dharmpal S Dodd, Steven Sheriff, ChiehYing J Chang, Dawn K Stetsko, Linda M Phillips, Dominique Potin

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.
Dominique Potin, Michele Launay, Francoise Monatlik, Patrice Malabre, Maud Fabreguettes

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
Dominique Potin, Michele Launay, Eric Nicolai, Maud Fabreguette, Patrice Malabre

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis